DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, KS | - |
dc.contributor.author | Hong, SW | - |
dc.contributor.author | Kim, H | - |
dc.contributor.author | Cho, M | - |
dc.contributor.author | Kim, S | - |
dc.contributor.author | Hur, W | - |
dc.contributor.author | Yun, SH | - |
dc.contributor.author | Yoon, SK | - |
dc.contributor.author | Hahn, SK | - |
dc.date.accessioned | 2016-04-06T07:32:05Z | - |
dc.date.available | 2016-04-06T07:32:05Z | - |
dc.date.created | 2016-01-26 | - |
dc.date.issued | 2015-05 | - |
dc.identifier.issn | 2046-2069 | - |
dc.identifier.other | 2015-OAK-0000034547 | - |
dc.identifier.uri | https://oasis.postech.ac.kr/handle/2014.oak/29856 | - |
dc.description.abstract | Cancer theranostic systems using polymeric micelles are emerging for simultaneous diagnosis and therapy. In this work, we have developed hyaluronate (HA)-Flt1 peptide conjugate micelles encapsulating epirubicin for theranostic treatment of hepatocellular carcinoma. Intravital bioimaging without labelling and in vivo anti-tumor therapeutic effect clearly confirmed the feasibility of HA-Flt1 peptide conjugate/epirubicin micelles for target-specific theranostic treatment of liver cancers. | - |
dc.description.statementofresponsibility | open | - |
dc.language | English | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.relation.isPartOf | RSC ADVANCES | - |
dc.subject | HYALURONIC-ACID DERIVATIVES | - |
dc.subject | DRUG-DELIVERY SYSTEMS | - |
dc.subject | POLYMERIC MICELLES | - |
dc.subject | ANTI-FLT1 PEPTIDE | - |
dc.subject | CONJUGATE | - |
dc.subject | DOXORUBICIN | - |
dc.subject | NEOVASCULARIZATION | - |
dc.subject | NANOPARTICLES | - |
dc.subject | EPIRUBICIN | - |
dc.subject | RECEPTOR | - |
dc.title | Hyaluronate-Flt1 peptide conjugate/epirubicin micelles for theranostic application to liver cancers | - |
dc.type | Article | - |
dc.contributor.college | 신소재공학과 | - |
dc.identifier.doi | 10.1039/C5RA07464A | - |
dc.author.google | Kim, KS | - |
dc.author.google | Hong, SW | - |
dc.author.google | Kim, H | - |
dc.author.google | Cho, M | - |
dc.author.google | Kim, S | - |
dc.author.google | Hur, W | - |
dc.author.google | Yun, SH | - |
dc.author.google | Yoon, SK | - |
dc.author.google | Hahn, SK | - |
dc.relation.volume | 5 | - |
dc.relation.issue | 60 | - |
dc.relation.startpage | 48615 | - |
dc.relation.lastpage | 48618 | - |
dc.contributor.id | 10149037 | - |
dc.relation.journal | RSC ADVANCES | - |
dc.relation.index | SCI급, SCOPUS 등재논문 | - |
dc.relation.sci | SCIE | - |
dc.collections.name | Journal Papers | - |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | RSC ADVANCES, v.5, no.60, pp.48615 - 48618 | - |
dc.identifier.wosid | 000355738300056 | - |
dc.date.tcdate | 2019-02-01 | - |
dc.citation.endPage | 48618 | - |
dc.citation.number | 60 | - |
dc.citation.startPage | 48615 | - |
dc.citation.title | RSC ADVANCES | - |
dc.citation.volume | 5 | - |
dc.contributor.affiliatedAuthor | Hahn, SK | - |
dc.identifier.scopusid | 2-s2.0-84930653450 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.wostc | 4 | - |
dc.description.scptc | 4 | * |
dc.date.scptcdate | 2018-05-121 | * |
dc.type.docType | Article | - |
dc.subject.keywordPlus | HYALURONIC-ACID DERIVATIVES | - |
dc.subject.keywordPlus | POLYMERIC MICELLES | - |
dc.subject.keywordPlus | ANTI-FLT1 PEPTIDE | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | CONJUGATE | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | EPIRUBICIN | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
library@postech.ac.kr Tel: 054-279-2548
Copyrights © by 2017 Pohang University of Science ad Technology All right reserved.